Tara Bancroft
Stock Analyst at TD Cowen
(1.78)
# 1,958
Out of 4,417 analysts
5
Total ratings
66.67%
Success rate
33.39%
Average return
Main Sectors:
Top Industries:
5 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GERN Geron | Initiates: Buy | $10 | $3.93 | +154.45% | 1 | Apr 29, 2024 | |
| FUSN Fusion Pharmaceuticals | Downgrades: Hold | n/a | $21.45 | - | 1 | Apr 16, 2024 | |
| OCUL Ocular Therapeutix | Maintains: Market Perform | $8 → $11 | $6.17 | +78.28% | 1 | Mar 12, 2024 | |
| MRUS Merus | Initiates: Outperform | n/a | $47.50 | - | 1 | Aug 21, 2023 | |
| BCYC Bicycle Therapeutics | Initiates: Outperform | n/a | $24.58 | - | 1 | Aug 31, 2022 |
Geron
Apr 29, 2024
Initiates: Buy
Price Target: $10
Current: $3.93
Upside: +154.45%
Fusion Pharmaceuticals
Apr 16, 2024
Downgrades: Hold
Price Target: n/a
Current: $21.45
Upside: -
Ocular Therapeutix
Mar 12, 2024
Maintains: Market Perform
Price Target: $8 → $11
Current: $6.17
Upside: +78.28%
Merus
Aug 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $47.50
Upside: -
Bicycle Therapeutics
Aug 31, 2022
Initiates: Outperform
Price Target: n/a
Current: $24.58
Upside: -